Shaolin Capital Management’s SBC Medical Group Warrants SBCWW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-50,000
Closed -$13.8K – 577
2026
Q1
$13.8K Sell
50,000
-25,000
-33% -$7.08K ﹤0.01% 485
2025
Q4
$15.2K Buy
75,000
+10,000
+15% +$1.72K ﹤0.01% 396
2025
Q3
$13.6K Sell
65,000
-35,000
-35% -$6.57K ﹤0.01% 318
2025
Q2
$19.3K Hold
100,000
– – ﹤0.01% 258
2025
Q1
$18.6K Sell
100,000
-24,820
-20% -$5.98K ﹤0.01% 168
2024
Q4
$30K Sell
124,820
-100,180
-45% -$24.2K ﹤0.01% 161
2024
Q3
$33.8K Sell
225,000
-185,755
-45% -$19.2K ﹤0.01% 149
2024
Q2
$29.2K Sell
410,755
-221,245
-35% -$16.1K ﹤0.01% 200
2024
Q1
$22.1K Hold
632,000
– – ﹤0.01% 230
2023
Q4
$17.8K Hold
632,000
– – ﹤0.01% 303
2023
Q3
$38K Buy
+632,000
New +$33.6K ﹤0.01% 325
2023
Q2
– Sell
-632,000
Closed -$29.6K – 721
2023
Q1
$30K Buy
632,000
+92,000
+17% +$5.95K ﹤0.01% 504
2022
Q4
$30K Hold
540,000
– – ﹤0.01% 526
2022
Q3
$54K Buy
+540,000
New +$44.9K ﹤0.01% 566

Other funds holding SBCWW

Shaolin Capital Management's SBCWW Position: Q2 2026 in Review

Shaolin Capital Management sold out of SBC Medical Group Warrants (SBCWW) in Q2 2026, closing a stake of 50,000 shares — an estimated $13.8K sold.

Shaolin Capital Management first reported a position in SBCWW in Q3 2022 and held it in 14 quarters. The position peaked at $54K in Q3 2022. 17 funds tracked by Wall St. Rank hold SBCWW as of Q2 2026.

  • Shaolin Capital Management reported no remaining SBC Medical Group Warrants position as of Q2 2026 after selling out during the quarter.
  • Shaolin Capital Management sold 50,000 SBC Medical Group Warrants shares in Q2 2026, an estimated $13.8K.
  • Shaolin Capital Management first reported a position in SBC Medical Group Warrants in Q3 2022 and held it in 14 quarters.
  • Shaolin Capital Management's SBC Medical Group Warrants position peaked at $54K in Q3 2022.
  • 17 funds tracked by Wall St. Rank held SBC Medical Group Warrants as of Q2 2026.

Based on Shaolin Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.